Ross Abrams to Aged, 80 and over
This is a "connection" page, showing publications Ross Abrams has written about Aged, 80 and over.
Connection Strength
0.441
-
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial. Am J Clin Oncol. 2020 03; 43(3):173-179.
Score: 0.087
-
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):809-16.
Score: 0.046
-
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008 Jul 20; 26(21):3503-10.
Score: 0.039
-
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):178-82.
Score: 0.035
-
Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998 May-Jun; 2(3):207-16.
Score: 0.019
-
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997 Sep; 226(3):248-57; discussion 257-60.
Score: 0.018
-
RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704. Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):554-60.
Score: 0.016
-
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clin Cancer Res. 2015 Dec 15; 21(24):5612-8.
Score: 0.016
-
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1166-71.
Score: 0.013
-
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86.
Score: 0.012
-
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol. 2011 May; 18(5):1319-26.
Score: 0.012
-
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.
Score: 0.012
-
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1328-35.
Score: 0.011
-
Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):985-91.
Score: 0.011
-
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
Score: 0.011
-
Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):831-5.
Score: 0.011
-
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008 Dec 20; 26(36):5918-22.
Score: 0.010
-
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008 Mar 05; 299(9):1019-26.
Score: 0.009
-
Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004 Feb; 27(1):51-6.
Score: 0.007
-
Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol. 2003 Dec 15; 21(24):4553-9.
Score: 0.007
-
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. J Clin Oncol. 2003 Apr 01; 21(7):1238-48.
Score: 0.007
-
Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):455-9.
Score: 0.006
-
Spiral CT of colon cancer: imaging features and role in management. Radiographics. 2000 Mar-Apr; 20(2):419-30.
Score: 0.005
-
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May; 225(5):621-33; discussion 633-6.
Score: 0.004
-
Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure. Radiographics. 1997 Mar-Apr; 17(2):303-13.
Score: 0.004
-
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst. 1997 Jan 15; 89(2):158-65.
Score: 0.004
-
Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun; 223(6):718-25; discussion 725-8.
Score: 0.004
-
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 1995 Apr; 45(4):616-23.
Score: 0.004